Episodic memory decline in Parkinson' s disease: relation with white matter hyperintense lesions and influence of quantification method.


Journal

Brain imaging and behavior
ISSN: 1931-7565
Titre abrégé: Brain Imaging Behav
Pays: United States
ID NLM: 101300405

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 28 6 2018
medline: 13 11 2019
entrez: 28 6 2018
Statut: ppublish

Résumé

The relation of white matter hyperintense lesions to episodic memory impairment in patients with Parkinson's disease (PD) is still controversial. We aimed at evaluating the relation between white matter hyperintense lesions and episodic memory decline in patients with PD. In this multicentric prospective study, twenty-one normal controls, 15 PD patients without mild cognitive impairment (MCI) and 13 PD patients with MCI were selected to conduct a clinico-radiological correlation analysis. Performance during episodic memory testing, age-related white matter changes score, total manual and automated white matter hyperintense lesions volume and lobar white matter hyperintense lesions volumes were compared between groups using the Kruskal-Wallis and Wilcoxon signed-rank tests, and correlations were assessed using the Spearman test. MCI PD patients had impaired free recall. They also had higher total, left prefrontal and left temporal white matter hyperintense lesions volumes than normal controls. Free recall performance was negatively correlated with the total white matter hyperintense lesions volume, either manually or automatically delineated, but not with the age-related white matter changes score. Using automated segmentation, both the left prefrontal and temporal white matter hyperintense lesions volumes were negatively correlated with the free recall performance. Early episodic memory impairment in MCI PD patients may be related to white matter hyperintense lesions, mainly in the prefrontal and temporal lobes. This relation is influenced by the method used for white matter hyperintense lesions quantification. Automated volumetry allows for detecting those changes.

Identifiants

pubmed: 29948903
doi: 10.1007/s11682-018-9909-x
pii: 10.1007/s11682-018-9909-x
pmc: PMC6538581
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

810-818

Références

Stroke. 2003 Feb;34(2):441-5
pubmed: 12574557
Neurology. 2004 May 11;62(9):1533-9
pubmed: 15136677
Mov Disord. 2006 Feb;21(2):223-9
pubmed: 16161159
J Cogn Neurosci. 2006 Mar;18(3):418-29
pubmed: 16513006
Stat Appl Genet Mol Biol. 2007;6:Article27
pubmed: 18052910
Neurol Neurochir Pol. 2008 Nov-Dec;42(6):505-12
pubmed: 19235103
Mov Disord. 2009 Jul 30;24(10):1437-44
pubmed: 19452554
Neuroimage. 2009 Oct 1;47(4):2083-9
pubmed: 19539037
Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):227-33
pubmed: 20473133
J Magn Reson Imaging. 2010 Jun;31(6):1311-22
pubmed: 20512882
Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):284-90
pubmed: 20683186
Neurology. 2011 Apr 26;76(17):1492-9
pubmed: 21518999
Mov Disord. 2012 Mar;27(3):349-56
pubmed: 22275317
Eur J Neurol. 2012 Aug;19(8):1100-7
pubmed: 22360775
Neurology. 2012 Jul 31;79(5):442-8
pubmed: 22815562
Neurodegener Dis. 2013;12(1):1-12
pubmed: 22831964
J Aging Res. 2013;2013:198471
pubmed: 23401776
J Int Neuropsychol Soc. 2013 Jul;19(6):695-708
pubmed: 23544964
Parkinsonism Relat Disord. 2013 Jul;19(7):680-3
pubmed: 23623194
J Magn Reson Imaging. 2015 Jan;41(1):102-9
pubmed: 24382798
Eur J Neurol. 2014 Jun;21(6):922-e50
pubmed: 24661277
Neuroimage Clin. 2014 Nov 08;7:7-17
pubmed: 25429357
Neuroimage Clin. 2015 Jan 27;7:482-92
pubmed: 25685715
J Neuroimaging. 2015 Sep-Oct;25(5):754-60
pubmed: 25753576
Neurology. 2015 Aug 4;85(5):441-9
pubmed: 26156514
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S166-70
pubmed: 26391185
Neurology. 2015 Nov 24;85(21):1843-51
pubmed: 26519540
J Magn Reson Imaging. 2016 Jun;43(6):1445-54
pubmed: 26606758
Cerebrovasc Dis. 2016;42(1-2):106-9
pubmed: 27071040
Mov Disord. 2016 Oct;31(10):1518-1526
pubmed: 27324570
AJNR Am J Neuroradiol. 2016 Dec;37(12):2310-2316
pubmed: 27418471
J Int Neuropsychol Soc. 2016 Nov;22(10):1005-1015
pubmed: 27903333
J Int Neuropsychol Soc. 2017 Apr;23(4):322-331
pubmed: 28162137
Parkinsonism Relat Disord. 2018 Apr;49:9-16
pubmed: 29310988

Auteurs

Vincent Dunet (V)

Department of Diagnostic and Interventional Radiology, Lausanne University Hospital, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland. Vincent.Dunet@chuv.ch.

Mario Joao Fartaria (MJ)

Department of Diagnostic and Interventional Radiology, Lausanne University Hospital, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
Advanced Clinical Imaging Technology, Siemens Healthcare HC CEMEA SUI DI PI, Lausanne, Switzerland.
Signal Processing Laboratory (LTS 5), Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Jeremy Deverdun (J)

Department of Neuroradiology, Montpellier University Hospital Center, Montpellier, France.
I2FH, Montpellier University Hospital Center, Montpellier, France.

Emmanuelle Le Bars (E)

Department of Neuroradiology, Montpellier University Hospital Center, Montpellier, France.
I2FH, Montpellier University Hospital Center, Montpellier, France.
Laboratoire Charles Coulomb, CNRS UMR 5221, University of Montpellier, Montpellier, France.

Florence Maury (F)

Department of Neurology, Montpellier University Hospital Center, Montpellier, France.

Giovanni Castelnovo (G)

Department of Neurology, Caremeau University Hospital Center, Nimes, France.

Tobias Kober (T)

Department of Diagnostic and Interventional Radiology, Lausanne University Hospital, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
Advanced Clinical Imaging Technology, Siemens Healthcare HC CEMEA SUI DI PI, Lausanne, Switzerland.
Signal Processing Laboratory (LTS 5), Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Meritxell Bach Cuadra (MB)

Department of Diagnostic and Interventional Radiology, Lausanne University Hospital, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
Signal Processing Laboratory (LTS 5), Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Medical Image Analysis Laboratory (MIAL), Centre d'Imagerie BioMédicale (CIBM), Lausanne, Switzerland.

Christian Geny (C)

Department of Neurology, Montpellier University Hospital Center, Montpellier, France.

Benedicte Marechal (B)

Department of Diagnostic and Interventional Radiology, Lausanne University Hospital, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
Advanced Clinical Imaging Technology, Siemens Healthcare HC CEMEA SUI DI PI, Lausanne, Switzerland.
Signal Processing Laboratory (LTS 5), Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Nicolas Menjot de Champfleur (NM)

Department of Neuroradiology, Montpellier University Hospital Center, Montpellier, France.
I2FH, Montpellier University Hospital Center, Montpellier, France.
Laboratoire Charles Coulomb, CNRS UMR 5221, University of Montpellier, Montpellier, France.
Department of Radiology, Caremeau University Hospital Center, Nimes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH